Ciclosporin topical
Alternative Names: ATH 002; Cyclosporin-DT; Dermosome Technology - ciclosporin; Dermosporin; DT-ciclosporin; Topical ciclosporinLatest Information Update: 02 Oct 2021
At a glance
- Originator Isdin
- Developer ISDIN
- Class Anti-inflammatories; Antineoplastics; Antipsoriatics; Antirheumatics; Ciclosporins; Eye disorder therapies; Heart failure therapies; Neuroprotectants
- Mechanism of Action Calcineurin inhibitors; Free radical inhibitors; Immunosuppressants; Mitochondrial permeability transition pore inhibitors; P-glycoprotein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Plaque psoriasis
Most Recent Events
- 21 Sep 2015 No recent reports of development identifed - Phase-I/II for Plaque psoriasis in Germany (Topical)
- 15 Apr 2008 Topical ciclosporin is still in phase I/II trials for Psoriasis in Germany
- 20 Feb 2007 Preclinical trials in Skin disorders in Spain (Topical)